SUSTAINED RELEASE OF SPRAY-DRIED COMBINATION DRY POWDER INHALER FORMULATION FOR PULMONARY DELIVERY Research Article

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Formulation strategy and use of excipients in pulmonary drug delivery.

  2010cited by this paper
• FORMULATION , EVALUATION AND COMPARISON OF SUSTAINED RELEASE MATRIX TABLETS OF DICLOFENAC SODIUM USING TAMARIND GUM AS RELEASE MODIFIER

  2010cited by this paper
• The relationship between drug concentration, mixing time, blending order and ternary dry powder inhalation performance.

  2010cited by this paper
• Can low-dose combination products for inhalation be formulated in single crystalline particles?

  2010cited by this paper
• Formulation, Evaluation and Comparison of Sustained Release Matrix Tablets of Diclofenac Sodium Using Natural Polymers as Release Modifier

  2010cited by this paper
• Sustained delivery by leucine-modified chitosan spray-dried respirable powders.

  2009cited by this paper
• Spray Drying Technology: an overview

  2009cited by this paper
• Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors.

  2009cited by this paper
• Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy.

  2009cited by this paper
• An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances.

  2008cited by this paper
• Coprocessing via spray drying as a formulation platform to improve the compactability of various drugs.

  2008cited by this paper
• Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate.

  2008cited by this paper
• Combination particles containing salmeterol xinafoate and fluticasone propionate: Formulation and aerodynamic assessment.

  2008cited by this paper
• Solid lipid microparticles as a sustained release system for pulmonary drug delivery.

  2007cited by this paper
• Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery.

  2007cited by this paper
• The influence of formulation components on the aerosolisation properties of spray-dried powders.

  2005cited by this paper
• CLASSIFYING FLOW PROPERTIES OF SOLIDS

  1965cited by this paper

• Novel Fluticasone Propionate and Salmeterol Fixed-Dose Combination Nano-Encapsulated Particles Using Polyamide Based on L-Lysine

  2022cites this paper
• Importance of Drying in Small Molecule Drug Product Development

  2020cites this paper
• Enhancement of the Solubility and Dissolution Rate of Rebamipide by Using Solid Dispersion Technique ( Part I )

  2018cites this paper
• Xyloglucan based Microspheres for Pulmonary Delivery of Rifabutin Dry Powder Inhaler

  2017influential citation
• Physicochemical characterization of spray dried cefixime polymeric nanoparticles using factorial design approach

  2016influential citation
• Microencapsulation of antitubercular drugs in a matrix of partially hydrolyzed guar gum, for application in tuberculosis treatment

  2015cites this paper